243 related articles for article (PubMed ID: 28374838)
1. A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3'end using CRISPR-Cas9 genome editing technique.
Basu S; Adams L; Guhathakurta S; Kim YS
Sci Rep; 2017 Apr; 8():45883. PubMed ID: 28374838
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease
Yoon HH; Ye S; Lim S; Jo A; Lee H; Hong F; Lee SE; Oh SJ; Kim NR; Kim K; Kim BJ; Kim H; Lee CJ; Nam MH; Hur JW; Jeon SR
CRISPR J; 2022 Feb; 5(1):95-108. PubMed ID: 35191750
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
4. Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein.
Mansour HM; El-Khatib AS
Ageing Res Rev; 2023 Dec; 92():102114. PubMed ID: 37924981
[TBL] [Abstract][Full Text] [Related]
5. Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening.
Dansithong W; Paul S; Scoles DR; Pulst SM; Huynh DP
PLoS One; 2015; 10(8):e0136930. PubMed ID: 26317803
[TBL] [Abstract][Full Text] [Related]
6. FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling.
Arias-Fuenzalida J; Jarazo J; Qing X; Walter J; Gomez-Giro G; Nickels SL; Zaehres H; Schöler HR; Schwamborn JC
Stem Cell Reports; 2017 Nov; 9(5):1423-1431. PubMed ID: 28988985
[TBL] [Abstract][Full Text] [Related]
7. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
Li Y; Li S; Li Y; Xia H; Mao Q
Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
[TBL] [Abstract][Full Text] [Related]
8. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a HEK293 cell line by CRISPR/Cas9-mediated luciferase knock-in to study transcriptional regulation of the human SREBP1 gene.
Li Z; Zhao J; Muhammad N; Wang D; Mao Q; Xia H
Biotechnol Lett; 2018 Dec; 40(11-12):1495-1506. PubMed ID: 30232659
[TBL] [Abstract][Full Text] [Related]
10. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
Chiba-Falek O; Nussbaum RL
Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease.
Zhu XX; Zhong YZ; Ge YW; Lu KH; Lu SS
Sci Rep; 2018 Aug; 8(1):12420. PubMed ID: 30127453
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.
Guhathakurta S; Bok E; Evangelista BA; Kim YS
Prog Neurobiol; 2017 Jul; 154():21-36. PubMed ID: 28445713
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a DGKθ Endogenous Promoter Luciferase Reporter HepG2 Cell Line for Studying the Transcriptional Regulation of DGKθ Gene.
Shan L; Wang D; Mao Q; Xia H
Appl Biochem Biotechnol; 2019 Apr; 187(4):1344-1355. PubMed ID: 30229432
[TBL] [Abstract][Full Text] [Related]
14. A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins.
Casalino E; Stine LB; Corin AJ; Thai CT; Quiroz J; Wilson SC; Labow M; Mittal S
SLAS Discov; 2022 Sep; 27(6):349-357. PubMed ID: 35580766
[TBL] [Abstract][Full Text] [Related]
15. Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson's disease.
Zafar F; Nallur Srinivasaraghavan V; Yang Chen M; Alejandra Morato Torres C; Schüle B
Stem Cell Res; 2022 Apr; 60():102733. PubMed ID: 35263701
[TBL] [Abstract][Full Text] [Related]
16. Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene.
Gao N; Li YH; Li X; Yu S; Fu GL; Chen B
Neurosci Bull; 2007 Jan; 23(1):53-7. PubMed ID: 17592526
[TBL] [Abstract][Full Text] [Related]
17. Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity.
Chen YC; Farzadfard F; Gharaei N; Chen WCW; Cao J; Lu TK
Mol Cell; 2017 Oct; 68(1):247-257.e5. PubMed ID: 28985507
[TBL] [Abstract][Full Text] [Related]
18. Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9.
Lu S; Zhou J
Neurosci Bull; 2017 Feb; 33(1):115-117. PubMed ID: 27743341
[TBL] [Abstract][Full Text] [Related]
19. Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time.
White CW; Vanyai HK; See HB; Johnstone EKM; Pfleger KDG
Sci Rep; 2017 Jun; 7(1):3187. PubMed ID: 28600500
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Assisted CRISPRi-Exosome for Epigenetic Modification of α-Synuclein Gene in a Mouse Model of Parkinson's Disease.
Kong W; Li X; Guo X; Sun Y; Chai W; Chang Y; Huang Q; Wang P; Wang X
ACS Nano; 2024 Mar; 18(11):7837-7851. PubMed ID: 38437635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
